ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
102 announcements with these filters
MedPlus reported Q4 FY26 consolidated revenue of INR 18,644 million with a 5.8% EBITDA margin. Strategy shifts toward a franchisee model for faster, capital-efficient expansion.
MedPlus subsidiary Optival Health Solutions received drug license suspension orders for two Karnataka stores. The temporary closures will result in a combined ₹0.03 Crore revenue loss.
Medplus delivered strong revenue growth while pivoting toward a franchise-led expansion model to optimize capital allocation. Management maintains a confident tone despite store closures and fluctuating private label contributions.
MedPlus Health Services subsidiary received two drug license suspension orders for stores in Telangana and Karnataka. The suspensions cause a ₹0.05 Crore total potential revenue loss.
Medplus Health Services approved the appointment of two independent directors and re-appointed Gangadi Madhukar Reddy. These leadership changes aim to strengthen corporate governance and strategic oversight.
MedPlus Health Services reports the resignation of Company Secretary Monoj Kumar Srivastava effective May 20, 2026. He departs to pursue external professional growth opportunities.
MedPlus FY26 revenue reached ₹68,925m, up 12.3% YoY. Strategy focuses on cluster-based expansion with 5,330 stores and increasing private label share.
MedPlus Health Services appointed two new independent directors and re-appointed its Managing Director for five-year terms. These leadership changes aim to strengthen corporate governance and stability.
MedPlus Health Services allotted 82,419 equity shares following ESOP exercises. Total paid-up capital increased to ₹24.02 Crore, reflecting employee benefit program execution.
Medplus Health Services Ltd reported revenue from operations of ₹1,864 Cr (+23.5% YoY) and net profit of ₹64 Cr (+24.8% YoY) for Q4 FY26.
MedPlus Health Services Limited reported audited financial results for FY2026. Consolidated net profit reached ₹219.61 Crore on total revenue of ₹6,963.79 Crore.
MedPlus subsidiary Optival Health Solutions received a three-day drug license suspension for a Telangana store. The event carries a potential ₹0.02 Crore revenue impact.